SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-15-122987
Filing Date
2015-04-08
Accepted
2015-04-08 17:23:34
Documents
4
Group Members
AURUM MERGER SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d904460dsc13d.htm SC 13D 84544
2 EX-2.1 d904460dex21.htm EX-2.1 414419
3 EX-2.2 d904460dex22.htm EX-2.2 48554
4 EX-99.1 d904460dex991.htm EX-99.1 3710
  Complete submission text file 0001193125-15-122987.txt   552881
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filed by) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3333 N. TORREY PINES COURT SUITE 400 LA JOLLA CA 92037
Business Address 3333 N. TORREY PINES COURT SUITE 400 LA JOLLA CA 92037 (858) 558-2400
Auspex Pharmaceuticals, Inc. (Subject) CIK: 0001454189 (see all company filings)

IRS No.: 954862842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87930 | Film No.: 15759813
SIC: 2834 Pharmaceutical Preparations